-
1 Comment
Pharmaniaga Bhd is currently in a long term downtrend where the price is trading 78.3% below its 200 day moving average.
From a valuation standpoint, the stock is 95.3% cheaper than other stocks from the Other sector with a price to sales ratio of 0.3.
Pharmaniaga Bhd's total revenue sank by 12.8% to $625M since the same quarter in the previous year.
Its net income has increased by 199.8% to $1M since the same quarter in the previous year.
Finally, its free cash flow fell by 647.5% to $-86M since the same quarter in the previous year.
Based on the above factors, Pharmaniaga Bhd gets an overall score of 2/5.
| ISIN | MYL7081OO002 |
|---|---|
| Exchange | KLSE |
| CurrencyCode | MYR |
| Sector | Healthcare |
| Industry | Medical Distribution |
| Market Cap | 382M |
|---|---|
| PE Ratio | 2.94 |
| Target Price | 0.39 |
| Beta | 1.35 |
| Dividend Yield | None |
Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. The company operates through three segments: Logistics and Distribution, Manufacturing, and Indonesia. It is involved in manufacturing, distribution, trading, wholesaling, and marketing pharmaceutical and medical products; supply, trading, and installation of medical and hospital equipment; and trading and wholesaling of consumer products. The company also manufactures and sells generic drugs; over-the-counter medicines; conducts research and development of pharmaceutical products; and manufactures, distributes, trades in, and sells food supplements. In addition, it distributes and trades in diagnostic products; and develops pharmacy management system for ordering management system, point-of-sale transactions, and inventory management. The company was founded in 1994 and is based in Shah Alam, Malaysia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 7081.KLSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
